Annual Symposium of the AHA Basic Cardiovascular Sciences Council

描述（由申请人提供）：这是美国心脏协会基础心血管科学委员会年度夏季研讨会的新申请。本次会议在过去的8年里得到了NHLBI的持续支持，去年的资助编号为R13 HL078309。NHLBI的支持促成了一次会议，该会议已成为处理分子心血管生物学和疾病的“必去”会议。它代表了它的发起人，美国心脏协会的基础心血管科学委员会，这是世界上领先的心血管科学家组织。这个会议最初开始于二十年前，当时理事会在1991年举行了一次分子心脏病学会议，然后举行了几次会议，最初被称为雪鸟会议，因为它是在夏天在犹他州雪鸟举行的。该会议于2002年成为年度活动，自2004年以来，该会议已被公认为美国心脏协会的永久性、经常性科学会议，R13也开始提供资金。近年来，会议开始混合了转化主题以及会议的“面包和黄油”，即基础分子心血管研究。该会议一直吸引着microrna、心脏基因和细胞治疗以及线粒体调控等领域的顶尖研究人员。参加这次会议的人数每年都在攀升，去年（2011年）在新奥尔良举行的会议有534名注册与会者，创下了历史记录。与往年一样，会议将于7月举行，并将再次在新奥尔良举行。计划的议程是一个雄心勃勃的、快节奏的会议，为期4天（2012年7月23日至26日），共有14场会议。今年的会议将在新奥尔良河畔希尔顿酒店举行，并由Eugene Braunwald博士和Shinya Yamanaka博士进行两次高调的主题演讲。年轻的心血管科学家也将在每个会议上通过邀请演讲来突出

DESCRIPTION (provided by applicant): This is a new application for the Annual Summer Symposium of the Basic Cardiovascular Sciences Council of the American Heart Association. This conference has had continuous support from the NHLBI for the last 8 years and last year was funded with the grant number of R13 HL078309. Support from the NHLBI has helped foster a meeting that has become the "go to" conference dealing with molecular cardiovascular biology and disease. It represents its sponsor, the Council on Basic Cardiovascular Sciences of the American Heart Association, which is the world's leading organization of cardiovascular scientists. This conference started originally two decades ago as the Council held a Molecular Cardiology conference in 1991 and then had several meetings initially hailed as the Snowbird Conference as it was held during the summer at Snowbird, Utah. The meeting became an annual event in 2002 and since 2004 this conference has been recognized as a permanent, recurring scientific meeting of the AHA and R13 funding also commenced. The conference in recent years has begun to mix in translational topics as well as the "bread and butter" of this meeting, which is basic molecular cardiovascular research. The conference has always attracted the leading researchers in fields such as microRNAs, cardiac gene and cell therapy and mitochondrial regulation. The attendance of this conference has climbed every year and last year (2011) the conference held in New Orleans had an all-time record attendance with 534 registered attendees. As in past years, the conference will be held in July and will once again be in New Orleans. The planned agenda represents an ambitious, fast-paced meeting with 14 sessions over 4 days (July 23-26, 2012). This year the meeting will be held at The Hilton New Orleans Riverside and have 2 high-profile Keynote lectures given by Dr. Eugene Braunwald and Dr. Shinya Yamanaka. Young cardiovascular scientists will be highlighted as well through invited talks in each session and Posters will be presented on 3 days of the conference. Organizers of this meeting are Drs. Yibin Wang (UCLA), Annarosa Leri (BWH, Harvard) and Roger Hajjar (Mt. Sinai). The proposal request constitutes approximately 7% of the total meeting budget and as over the last several years, support from this application will be used toward Cardiovascular Outreach Awards (minority travel awards) and New Investigator Travel Awards. PUBLIC HEALTH RELEVANCE: This proposal is for support of the annual conference of the Basic Cardiovascular Sciences Council of the American Heart Association. This meeting meets every July and is attended by basic and translational cardiovascular scientists where scientific exchange in this field is at its highest level. This meeting and those like it can accelerae discoveries pertinent to new therapies for heart disease, which are greatly needed. This meeting is a great learning experience for junior scientists and trainees and thus, optimizes the future return of investment in medical research by public dollars.